Table 2:

Spearman correlations between trauma severity and key sociodemographic, mental, and physical health variables in the study participants with and without schizophrenia

	Non-psychiatric participants Total CTQ score			Schizophrenia Total CTQ score			Test for equal correlations
	r	p	N	r	p	N	z	p
Sociodemographic
Age at visit	0.071	0.48	99	−0.039	0.68	114	0.79	0.21
Education (years)	−0.187	0.06	99	−0.101	0.29	114	−0.63	0.27
Psychopathology
Duration of Illness				0.13	0.18	111
Antipsychotic dose (mg)a				−0.077	0.41	114
Positive symptomsb				0.131	0.17	114
Negative symptomsc				0.015	0.87	114
Depressive symptomsd	0.341	0.001	98	0.024	0.8	114	2.35	0.009
Anxiety symptomse	0.202	0.06	90	0.089	0.35	111	0.8	0.21
Mental Health
Resiliencef	−0.074	0.49	90	−0.204	0.03	110	0.92	0.18
Mental well-beingg	−0.209	0.05	90	−0.1	0.3	111	−0.77	0.22
Perceived Stressh	0.21	0.05	89	0.119	0.21	111	0.64	0.26
Overall cognitive dysfunctioni	−0.15	0.14	97	0.105	0.28	111	−1.83	0.03
Executive Functioningj	−0.096	0.35	99	−0.06	0.53	114	−0.26	0.4
Physical Health
Physical well-beingk	−0.292	0.005	90	−0.251	0.008	111	−0.3	0.38
Physical comorbidityl	0.275	0.006	99	0.062	0.52	114	1.57	0.06
BMI	0.144	0.16	99	0.29	0.002	112	−1.08	0.14
Biomarkers
Fasting glucose (mg/dL)	0.064	0.53	99	0.094	0.32	113	−0.22	0.41
Fasting insulin (mIU/L)	0.266	0.009	95	0.231	0.02	106	0.25	0.4
Hemoglobin A1C (%)	0.13	0.23	85	0.13	0.21	95	0	0.5
HOMA-IR	0.26	0.01	95	0.227	0.02	106	0.24	0.4

^aAntipsychotic medication daily dosages were converted to WHO average daily doses based on published standards [WHO: Guidelines for ATC classification and DDD assignment, 2010 and WHO: Introduction to Drug Utilization Research, 2009]

^bAs assessed with the Scale for the Assessment of Positive Symptoms (SAPS) total summary score of the four global domain scores (ranging from 0 to 20, higher scores indicating more positive symptoms)

^cAs assessed with the Scale for the Assessment of Negative Symptoms (SANS) total summary score of the five global domain scores (ranging from 0 to 25, higher scores indicating more negative symptoms)

^dAs assessed with the Calgary Depression Scale total score (ranging from 0 to 27, higher scores indicating more depressive symptoms)

^eAs assessed with the Brief Symptom Inventory Anxiety Scale total score (ranging from 0 to 24, higher scores indicating more anxiety symptoms)

^fAs assessed with the Connor Davidson Resilience 10-item Scale (ranging from 0 to 40, higher scores indicating greater overall resilience)

^gAs assessed with the Short Form Health Survey (SF-36) Mental Composite score (computable range from −1.3 to 62.1, higher scores indicating better mental well-being)

^hAs assessed with the Perceived Stress Scale (ranging from 0 to 40, higher scores indicating greater perceived stress)

ⁱAs assessed with the Modified Telephone Interview for Cognitive Status (TICS-M) (ranging from 0 to 50, higher scores indicating better cognitive status)

^jAs assessed with the Delis-Kaplan Executive Function System (reported as a standardized z-score, with higher values indicating better executive functioning)

^kAs assessed with the Short Form Health Survey (SF-36) Physical Composite score (computable range from 1.7 to 76.3 from 0 to 100, higher scores indicating better physical well-being)

^lAs assessed with the Cumulative Illness Rating Scale total score (ranging from 0 to 56, higher scores indicating a higher number or greater severity of physical comorbidities)

Abbreviations: CTQ = Childhood Trauma Questionnaire, Hemoglobin A1c = glycosylated hemoglobin, HOMA-IR = Homeostatic Model Assessment for Insulin Resistance